Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AltheRx Pharmaceuticals
Malvern, Pennsylvania, United Statesaltherx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Solabegron, AltheRx’s lead program, demonstrated statistically significant improvements in OAB symptoms versus placebo and favorable safety in Phase 2, with additional Phase 2 data in IBS showing significant reduction in pain; the company planned to advance to Phase 3 for OAB and initiate a Phase 2b study for IBS before clinical/program assets were transferred via merger to Velicept Therapeutics
- Therapeutic areas
- UrologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
None disclosed prior to merger
Beyond the preview
Go deeper on AltheRx Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AltheRx Pharmaceuticals.